Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses

被引：5
作者：
Arnall, Justin R. [1 ]
Moore, Donald C. [1 ]
Hill, Hailey L. [2 ]
Griffin, Sarah [3 ]
Mueller, Maxine K. [1 ]
Lavery, Lesli A. [1 ]
Voorhees, Peter M. [4 ]
Usmani, Saad Z. [4 ]
机构：
[1] Atrium Hlth, Levine Canc Inst, Dept Pharm, 1021 Morehead Med Dr, Charlotte, NC 28204 USA
[2] Atrium Hlth, Carolinas Med Ctr, Dept Pharm, Charlotte, NC USA
[3] Inova Fairfax Hosp, Falls Church, VA USA
[4] Atrium Hlth, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA
来源：
LEUKEMIA & LYMPHOMA | 2019年 / 60卷 / 09期
关键词：
DEXAMETHASONE; MONOTHERAPY; BORTEZOMIB;
D O I：
10.1080/10428194.2019.1576871
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2295 / 2298
页数：4
相关论文
共 12 条
  • [1] [Anonymous], 2017, DARZ DAR PRESCR INF
  • [2] Cejalvo MJ, 2017, BLOOD, V130
  • [3] Chari A, 2019, BLOOD, V128, P2142
  • [4] Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
    Chari, Ajai
    Suvannasankha, Attaya
    Fay, Joseph W.
    Arnulf, Bertrand
    Kaufman, Jonathan L.
    Ifthikharuddin, Jainulabdeen J.
    Weiss, Brendan M.
    Krishnan, Amrita
    Lentzsch, Suzanne
    Comenzo, Raymond
    Wang, Jianping
    Nottage, Kerri
    Chiu, Christopher
    Khokhar, Nushmia Z.
    Ahmadi, Tahamtan
    Lonial, Sagar
    [J]. BLOOD, 2017, 130 (08) : 974 - 981
  • [5] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Dimopoulos, M. A.
    Oriol, A.
    Nahi, H.
    San-Miguel, J.
    Bahlis, N. J.
    Usmani, S. Z.
    Rabin, N.
    Orlowski, R. Z.
    Komarnicki, M.
    Suzuki, K.
    Plesner, T.
    Yoon, S. -S.
    Ben Yehuda, D.
    Richardson, P. G.
    Goldschmidt, H.
    Reece, D.
    Lisby, S.
    Khokhar, N. Z.
    O'Rourke, L.
    Chiu, C.
    Qin, X.
    Guckert, M.
    Ahmadi, T.
    Moreau, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (14) : 1319 - 1331
  • [6] Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
    Lokhorst, H. M.
    Plesner, T.
    Laubach, J. P.
    Nahi, H.
    Gimsing, P.
    Hansson, M.
    Minnema, M. C.
    Lassen, U.
    Krejcik, J.
    Palumbo, A.
    van de Donk, N. W. C. J.
    Ahmadi, T.
    Khan, I.
    Uhlar, C. M.
    Wang, J.
    Sasser, A. K.
    Losic, N.
    Lisby, S.
    Basse, L.
    Brun, N.
    Richardson, P. G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13) : 1207 - 1219
  • [7] Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
    Lonial, Sagar
    Weiss, Brendan M.
    Usmani, Saad Z.
    Singhal, Seema
    Chari, Ajai
    Bahlis, Nizar J.
    Belch, Andrew
    Krishnan, Amrita
    Vescio, Robert A.
    Victoria Mateos, Maria
    Mazumder, Amitabha
    Orlowski, Robert Z.
    Sutherland, Heather J.
    Blade, Joan
    Scott, Emma C.
    Oriol, Albert
    Berdeja, Jesus
    Gharibo, Mecide
    Stevens, Don A.
    LeBlanc, Richard
    Sebag, Michael
    Callander, Natalie
    Jakubowiak, Andrzej
    White, Darrell
    de la Rubia, Javier
    Richardson, Paul G.
    Lisby, Steen
    Feng, Huaibao
    Uhlar, Clarissa M.
    Khan, Imran
    Ahmadi, Tahamtan
    Voorhees, Peter M.
    [J]. LANCET, 2016, 387 (10027) : 1551 - 1560
  • [8] Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
    Mateos, M. -V.
    Dimopoulos, M. A.
    Cavo, M.
    Suzuki, K.
    Jakubowiak, A.
    Knop, S.
    Doyen, C.
    Lucio, P.
    Nagy, Z.
    Kaplan, P.
    Pour, L.
    Cook, M.
    Grosicki, S.
    Crepaldi, A.
    Liberati, A. M.
    Campbell, P.
    Shelekhova, T.
    Yoon, S. -S.
    Iosava, G.
    Fujisaki, T.
    Garg, M.
    Chiu, C.
    Wang, J.
    Carson, R.
    Crist, W.
    Deraedt, W.
    Nguyen, H.
    Qi, M.
    San-Miguel, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (06) : 518 - 528
  • [9] Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
    Palumbo, Antonio
    Chanan-Khan, Asher
    Weisel, Katja
    Nooka, Ajay K.
    Masszi, Tamas
    Beksac, Meral
    Spicka, Ivan
    Hungria, Vania
    Munder, Markus
    Mateos, Maria V.
    Mark, Tomer M.
    Qi, Ming
    Schecter, Jordan
    Amin, Himal
    Qin, Xiang
    Deraedt, William
    Ahmadi, Tahamtan
    Spencer, Andrew
    Sonneveld, Pieter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (08) : 754 - 766
  • [10] Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma
    Rocchi, Serena
    Tacchetti, Paola
    Pantani, Lucia
    Mancuso, Katia
    Zannetti, Beatrice
    Cavo, Michele
    Zamagni, Elena
    [J]. HAEMATOLOGICA, 2018, 103 (06) : E277 - E278
12